Amoxicillin Research Overview
Novamox 500 mg is an amoxicillin antibiotic formulation manufactured by Cipla containing 500 mg amoxicillin trihydrate per capsule. Amoxicillin belongs to the beta-lactam penicillin class of antimicrobial compounds, functioning through bacterial cell wall synthesis inhibition. This preparation enables researchers to investigate broad-spectrum antibiotic mechanisms and bacterial resistance patterns in controlled laboratory environments. The standardised dosage format facilitates consistent research protocols across multiple experimental designs.
Researchers examining antimicrobial compounds often source materials from Stroid UK Shop, ensuring reliable quality for laboratory investigations. This amoxicillin preparation complements studies involving other research compounds available in categories such as SARMs for cellular research and peptides for biochemical analysis.
Laboratory Research Applications
Amoxicillin research encompasses microbiological susceptibility testing, pharmacokinetic modelling, and resistance mechanism studies. Scientists examine this compound’s activity against gram-positive and gram-negative bacterial strains in culture systems. Research protocols evaluate minimum inhibitory concentrations, bactericidal kinetics, and synergistic effects with other antimicrobial agents. The compound serves as a reference standard in antibiotic potency assays and stability studies under various environmental conditions.
Academic institutions utilise amoxicillin preparations for educational purposes, demonstrating antibiotic mechanisms to students studying microbiology and pharmaceutical sciences. Quality control laboratories analyse formulation characteristics, dissolution rates, and impurity profiles. Pharmaceutical research organisations investigate novel delivery systems and combination therapies incorporating amoxicillin as an active component.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Amoxicillin Trihydrate |
| Strength | 500 mg per capsule |
| Manufacturer | Cipla Limited |
| Dosage Form | Hard gelatin capsules |
| CAS Number | 26787-78-0 |
| Molecular Formula | C₁₆H₁₉N₃O₅S·3H₂O |
| Molecular Weight | 419.45 g/mol |
| Storage | Below 25°C, dry place |
Research Compliance
Novamox 500 mg capsules are supplied strictly for in-vitro research and laboratory analysis purposes only. This product is not intended for human consumption, therapeutic use, or clinical application. Researchers must possess appropriate qualifications and facilities for handling pharmaceutical compounds safely. All studies should follow institutional guidelines for antimicrobial research and waste disposal protocols. Additional information about antibiotics for research applications can be accessed through our specialised category pages.
